SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+1.14%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.7B
AUM Growth
-$86.8M
(-3.1%)
Cap. Flow
+$24.7M
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
42.98%
Holding
115
New
16
Increased
19
Reduced
23
Closed
18
Top Buys
| 1 |
Legend Biotech
LEGN
|
$114M |
| 2 |
Immatics
IMTX
|
$36M |
| 3 |
Coca-Cola
KO
|
$34.2M |
| 4 |
Rocket Pharmaceuticals
RCKT
|
$32.3M |
| 5 |
Boeing
BA
|
$27.5M |
Top Sells
| 1 |
Apple
AAPL
|
$78.3M |
| 2 |
Arcellx
ACLX
|
$57.6M |
| 3 |
Royalty Pharma
RPRX
|
$52.8M |
| 4 |
AT&T
T
|
$50.3M |
| 5 |
UnitedHealth
UNH
|
$36.2M |
Sector Composition
| 1 | Healthcare | 60.76% |
| 2 | Consumer Discretionary | 9.71% |
| 3 | Technology | 9.58% |
| 4 | Financials | 6.08% |
| 5 | Communication Services | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
UnitedHealth
UNH
$279B
| $38M | 1.3% |
75,198
-71,647
| -49% | -$36.2M |
|
27
Oracle
ORCL
$628B
| $37.7M | 1.29% |
226,318
-10,776
| -5% | -$1.8M |
|
|
28
Immatics
IMTX
$662M
| $36M | 1.23% |
+5,065,277
| New | +$36M |
|
29
Boston Scientific
BSX
$159B
| $35.5M | 1.21% |
397,679
+145,990
| +58% | +$13M |
|
30
GE Aerospace
GE
$293B
| $33.5M | 1.14% |
200,662
| – | – |
|
|
31
Rocket Pharmaceuticals
RCKT
$358M
| $32.3M | 1.1% |
+2,566,951
| New | +$32.3M |
|
32
Erasca
ERAS
$406M
| $30.9M | 1.05% |
12,315,004
-1,453,035
| -11% | -$3.65M |
|
33
McDonald's
MCD
$226B
| $30M | 1.02% |
103,638
| – | – |
|
34
Verizon
VZ
$184B
| $29.5M | 1.01% |
738,414
-20,260
| -3% | -$810K |
|
|
35
Boeing
BA
$176B
| $27.5M | 0.94% |
+155,197
| New | +$27.5M |
|
36
Caesars Entertainment
CZR
$5.18B
| $25.8M | 0.88% |
+772,412
| New | +$25.8M |
|
37
Apellis Pharmaceuticals
APLS
$3.51B
| $25.3M | 0.86% |
+793,187
| New | +$25.3M |
|
38
Datadog
DDOG
$46.2B
| $25.2M | 0.86% |
+176,450
| New | +$25.2M |
|
|
CTNM
39
Contineum Therapeutics
CTNM
$297M
| $25.2M | 0.86% |
1,720,000
| – | – |
|
40
NVIDIA
NVDA
$4.15T
| $24.3M | 0.83% |
+180,756
| New | +$24.3M |
|
41
ProKidney
PROK
$319M
| $20.9M | 0.71% |
12,341,266
| – | – |
|
42
Abeona Therapeutics
ABEO
$356M
| $20.5M | 0.7% |
3,685,503
| – | – |
|
43
Johnson & Johnson
JNJ
$429B
| $20.2M | 0.69% |
139,986
+1,539
| +1% | +$223K |
|
44
United Airlines
UAL
$34.4B
| $19.5M | 0.66% |
+200,650
| New | +$19.5M |
|
45
Biogen
BIIB
$20.8B
| $17.7M | 0.6% |
115,436
+85,490
| +285% | +$13.1M |
|
46
Domino's
DPZ
$15.8B
| $16.1M | 0.55% |
+38,340
| New | +$16.1M |
|
47
Fulcrum Therapeutics
FULC
$353M
| $15.7M | 0.53% |
3,338,466
+2,155,675
| +182% | +$10.1M |
|
48
InflaRx
IFRX
$117M
| $14.2M | 0.48% |
5,733,910
| – | – |
|
49
Sutro Biopharma
STRO
$85.6M
| $13.7M | 0.47% |
7,462,495
+275,000
| +4% | +$506K |
|
50
CrowdStrike
CRWD
$104B
| $12.3M | 0.42% |
36,093
-86,062
| -70% | -$29.4M |
|